Abstract:S5.4 Free oral paper session, September 22, 2022, 3:00 PM - 4:30 PMObjective: Recent genome-wide genotype-phenotype association studies (GWAS) of sets of clinical fungal isolates have reported problems resulting from strong phylogenetic clustering (apparent quasi-clonal population structure, difficulties in localizing association signals on chromosomes). We wished to directly investigate such difficulties, for whole-genome sequence data, and corresponding phenotypic data we had generated.MethodsOur recently released Illumina read sequences (Bioproject PRJNA669191) for 29 clinical Colombian isolate genomes of Cryptococcus neoformans var. grubii (28 VNI and 1 VNII as outgroup) 1 2 were assembled and aligned to the annotated H99 VNI reference genome. Single nucleotide polymorphisms (SNPs) were called for the VNI alignment. MLST types, phenotypes, and source metadata of the same isolates 1 2 were integrated with the genomic data. Analyses were interpreted in the light of published literature.ResultsThe 28 VNI isolates were assigned an order considering MLST classification and whole-genome phylogenetic distances. Most SNPs were biallelic, allowing straightforward barcoding: each of the 28 isolates was given a bar if it had the minor allele. Barcode profiles (SNP state vectors) were found repeated numerous times within genes and across entire chromosomes, indicating that neither fine nor 'rough' mapping of associations would succeed, except where flagged genes had already been characterized by relevant molecular biology experiments. The same repetitiveness can allow amplicons of individual MLST loci to tag and inform on variation present in other loci in the genome. The gene for the capsule-associated protein CAP59 and its promoter region illustrate such implications at a small (genic) scale.Conclusions: Most associations of phenotypes with fungal genomes from modestly sampled clinical isolate populations cannot be localized to one or a few regions in a genome. This problem is less restrictive in human GWAS studies or (possibly) in studies of recombining fungi sampled from the environment 3 . It limits the benefits for molecular etiologic understanding that one might expect from GWAS of isolates obtained in clinical contexts, where key fungal phenotypes can be under stronger selection pressure. Explanatory power may be low if one compares just MLST types or phylogenetic clusters 4 or examines only variation within individual MLST types. More informative results may be gained by restricting the genomic search space a priori to a subset of genes that are likely to be related to a phenotype, and then zooming in to individual SNPs that are known/suspected to affect protein structure/function 1 or influence transcription/translation of the gene. Where the modes of regulation of a key gene are still not completely characterized despite decades of research, such as in CAP59, the presence of a phenotypically monitored, lone SNP in a strategic position within an almost SNP-less region can give potentially precious hints where otherwise none exist; we illustrate this strategy of SNP-focused local exploration for the promoter/enhancer and currently used MLST amplicon of CAP59.Sources: Vélez N, Vega-Vela N, et al. (2022), J Fungi 8(3):245. Vélez N, Monteoliva L, et al. (2022). J Fungi 8(1):57. Whiston E, Taylor JW (2015). G3 6(2):235-244. Felsenstein J (2008). Am Nat. 171(6):713-725.

Genomic Variation across a Clinical Cryptococcus Population Linked to Disease Outcome

Genome Variation in Cryptococcus Gattii, an Emerging Pathogen of Immunocompetent Hosts

Population genomics and the evolution of virulence in the fungal pathogen Cryptococcus neoformans

Associations between Cryptococcus Genotypes, Phenotypes, and Clinical Parameters of Human Disease: A Review

Human immune polymorphisms associated with the risk of cryptococcal disease

Integration of genomic and pharmacokinetic data to predict clinical outcomes in HIV-associated cryptococcal meningitis

Cryptococcal genotype influences immunologic response and human clinical outcome after meningitis

S5.4b Genomic variation structure in clinical isolate collections alters benefits of association screening: a study of Cryptococcus neoformans var. grubii in Colombia

Molecular Epidemiology and Antifungal Resistance of Cryptococcus neoformans From Human Immunodeficiency Virus-Negative and Human Immunodeficiency Virus-Positive Patients in Eastern China

Virulence-associated variants in Cryptococcus neoformans sequence type 93 are less likely to be associated with population structure compared to independent rare mutations

Cryptococcus: from environmental saprophyte to global pathogen

Genome-Wide Association Study Identifies Novel Colony Stimulating Factor 1 Locus Conferring Susceptibility to Cryptococcosis in Human Immunodeficiency Virus-Infected South Africans

Ex vivo host transcriptomics during Cryptococcus neoformans , Cryptococcus gattii , and Candida albicans infection of PBMCs from South African volunteers

Transcriptional Profiling of Patient Isolates Identifies a Novel TOR/Starvation Regulatory Pathway in Cryptococcal Virulence

Physiological Differences in Cryptococcus neoformans Strains In Vitro versus In Vivo and Their Effects on Antifungal Susceptibility

Pleiotropy and epistasis within and between signaling pathways defines the genetic architecture of fungal virulence

Advances in Understanding Human Genetic Variations That Influence Innate Immunity to Fungi

Microbiological and Clinical Characteristics of Cryptococcemia: a Retrospective Analysis of 85 Cases in a Chinese Hospital

The clinical and prognostic analysis of 50 patients with cryptococcemia

Multi-Locus Sequence Typing-Based Genetic Analysis, Antifungal Resistance, and Clinical Prognosis of Cryptococcus neoformans Infections in HIV-Infected Patients in Northern China

Clinical Features and Outcomes of Cryptococcemia Patients with and Without HIV Infection